Bolstran 150mg Injection
Marketer
Cipla Ltd
Salt Composition
Omalizumab (150mg)
Overview Bolstran 150mg Injection
Asthmanex 150mg Injection, a monoclonal antibody therapy, treats moderate-to-severe asthma in adults and children. It alleviates asthma symptoms like wheezing, shortness of breath, chest tightness, and coughing. Administered via injection under medical supervision, the initial three doses are given by a physician who will instruct you on self-injection at home. Dosage is tailored to individual symptom improvement. Continue using Asthmanex as prescribed, even if symptoms subside. Common side effects include joint pain, generalized pain, tiredness, lightheadedness, bone fractures, itching, skin rash, upper abdominal discomfort, cold symptoms, headache, and earache. Report any concerning or persistent side effects to your doctor; management strategies may be available. Note: Asthmanex does not prevent acute asthma attacks; always keep your rescue inhaler handy. Prior to commencing treatment, inform your doctor about any liver or kidney conditions, pregnancy, or pregnancy plans, and all other medications you are using, as interactions may affect Asthmanex's efficacy. Alcohol consumption is generally discouraged during treatment.
Primary Ingredients of Bolstran 150mg Injection
No information provided. Therefore, no text can be rewritten.
Uses of Bolstran 150mg Injection
Bronchial hyperresponsiveness
Major Benefits of Bolstran 150mg Injection:
Administering this medication will be done by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Bolstran 150mg Injection:
- Joint pain
- Pain
- Fatigue
- Dizziness
- Fracture
- Itching
- Dermatitis
- Upper abdominal pain
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Ear pain
How to use Bolstran 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bolstran 150mg Injection works:
Xolair 150mg Injection, a targeted monoclonal antibody, neutralizes immunoglobulin E proteins, thereby mitigating their contribution to asthma.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Bolstran 150mg Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Bolstran, 150mg dose, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; clinical data from human trials, however, remain scarce.
Breast feedingCONSULT YOUR DOCTOR
The use of Bolstran 150mg Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by a 150mg Bolstran injection.
KidneySAFE IF PRESCRIBED
The use of Bolstran 150mg Injection in patients with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary for this patient group. However, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Bolstran 150mg Injection in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may not be necessary. Physician consultation is advised.
What if you forget to take Bolstran 150mg Injection :
NA
Facts to Know About Bolstran 150mg Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Breathing |
| Behavioral Class | Monoclonal anti-IgE antibodies |
3,018 People bought this recently